in

January/February 2020

In this issue
  • in

    Novartis Oncology Head: from Medicine to Management

    Emanuele Ostuni, currently Novartis Head of Cell and Gene Therapy in Europe, has seen patients up close since he was a boy in southern Italy. He is now living his dream job helping patients as Europe Head, Cell and Gene Therapy at Novartis Oncology. The interview, by Jill Donahue As a young boy, Emanuele’s father, a […] More

    Read More

  • in

    INDUSTRY TRENDS: BY THE NUMBERS

    $300B Size of US medical device market in 2030 The projected size of the US medical device market will top $300 billion by 2030, according to a KPMG report. China will grow to $200B, followed by France, Germany, India, Japan and the UK. Source: KPMG International Strategy Group Report on Medical Devices 2030, published in […] More

    Read More

  • in

    Teva, Sanofi, Biomarin, Janssen and Others Recognized at eyeforpharma Awards

    On December 11th in Philadelphia, the eyeforpharma Awards 2019 celebrated 16 winners making genuine innovation visible, setting the bar higher and broadening the possibilities for pharma by showing what can be achieved. The eyeforpharma organization recently became part of Thomson Reuters, under its new Reuters Events division. The eyeforpharma mission is to make the industry […] More

    Read More

  • in

    Admedus COO David St. Denis on Courage, Commitment and Conversation

    David St. Denis is currently Chief Operating Officer and member of the executive board at Admedus, a structural heart company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Its focus is on investing in and developing next generation technologies with world class partners and acquiring strategic assets to grow product […] More

    Read More

  • in

    VANTAGE 2020 PREVIEW

    Evaluate provides trusted commercial intelligence for the healthcare industry. Below are highlights from their Vantage 2020 Preview of the biopharma sector. BIOPHARMA IS BRACED FOR A ROCKY RIDE IN 2020 The highlights: Rhetoric around drug pricing is only going to increase as the US presidential election gets closer, keeping a sector already unpopular with voters […] More

    Read More

  • in

    Lumicell, Roche, and Boston Scientific execs share their views on Point of Care

    MEET OUR EXPERTS: BILLIE BRUSH Consultant Billie Brush Consulting JAY GRAVES Founder and CEO Pathfinder Business Consultants Former VP Sales Roche Diabetes Care MEET OUR MODERATOR: BEN LOCWIN Healthcare Futurist SVP of Quality Lumicell AMEE PATEL VP of Human Resources Lumicell Founder Boylston Consulting Group SCOT NOEL Principal Consultant NOELEDGE Corner Consulting Former Group Sr. […] More

    Read More

  • in

    Are you taking advantage of the Gig Economy?

    It offers flexibility, specialized skills and more With the rise of the U.S. gig economy, more and more companies are taking advantage of the resources outside of their own doors And the life sciences industry is at the forefront. According to a recent survey by Experts OnTap, 77% of life science leaders leverage external consulting […] More

    Read More

  • in

    MOTIVIDEOS

    How bright-eyed and active are you at your morning meeting? It always helps to have some insights from people who have lived long, studied human habits, or just acquired wisdom in their own unique way. Here again are our kickoff videos that could help the motivation of your staff.By Cari Kraft, Jacobs Management Group Discipline […] More

    Read More

  • in

    Former BD and J&J Exec on the Secrets of Building a Marketing Strategy That Gets Results

    Rick Thomas started at the top of the industry, at Johnson & Johnson, and he credits this experience as contributing to the wisdom he brought to all his subsequent assignments. Primarily, he says that the J&J Credo was influential to him.By Rick Thomas, CEO, Innovation Health Resources It’s a simple document, but powerful in its […] More

    Read More

What do you think?

Written by hsandm

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Admedus COO David St. Denis on Courage, Commitment and Conversation

viscira Digital for Life